4-(3-(methylsulfonyl)phenyl)-1-propylpiperidine,
4-(3-methanesulfonylphenyl)-1-propylpiperidine,
ACR16 compound,
huntexil,
pridopidine,
PRIDOPIDINE,
346688-38-8,
4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine,
4-(3-(Methylsulfonyl)phenyl)-1-propylpiperidine,
ACR-16,
UNII-HD4TW8S2VK,
ACR16,
ACR 16,
HD4TW8S2VK,
CHEMBL596802,
FR310826,
Pridopidine [USAN:INN],
Pridopidine (USAN/INN),
4-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine,
SCHEMBL166748,
CTK4H2809,
DTXSID90188225,
ASP 2314,
BDBM50308028,
MFCD09835586,
ZINC22063703,
AKOS015891431,
DB11947,
NCGC00386586-01,
AJ-80925,
AK136772,
AS-50146,
HY-10684,
AX8258340,
DB-014417,
FR 310826,
CS-0002733,
FT-0672149,
4-(3-Methylsulfonylphenyl)-1-propylpiperidine,
D09953,
I01-9534,
Piperidine, 4-(3-(methylsulfonyl)phenyl)-1-propyl-,
Huntexil,
ACR16 compound,
Pridopidine [USAN],
D01FNJ,
D0F4SY,
PRIDOPIDINE HYDROCHLORIDE,
ASP-2314,
CID9795739,
FR-310826,
Dopamine modulator (schizophrenia), Astellas,
Dopamine modulator (schizophrenia), Fujisawa,
4-(3-methylsulfonylphenyl)-1-propyl-piperidine,
Dopamine modulator (Huntingtons disease), NeuroSearch,
Piperidine, 4-[3-(methylsulfonyl)phenyl]-1-propyl-,
Dopamine modulator (neurological disorders), Merck & Co,
Dopamine modulator (Huntingtons disease), Carlsson Research,